7.12 USD
↗ 0.21 (3.04%)LIVE (AS OF 10:29 AM EDT)
Neuraxis, Inc.
NRXSAMEX • USD
Market: OPEN
NRXS is currently priced at $7.12. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jun 25, 2026.
Open?$6.88
High?$7.12
Low?$6.88
Prev. Close?$6.91
Volume?15.9K
Avg. Volume?119.4K
VWAP?$6.95
Rel. Volume?0.13x
Bid / Ask
Bid?$7.04 × 100
Ask?$7.20 × 300
Spread?$0.16
Midpoint?$7.12
Valuation & Ratios
Market Cap?85.6M
Shares Out?12.4M
Float?6.3M
Float %?56.2%
P/E Ratio?N/A
P/B Ratio?14.89
EPS?-$0.65
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Employees
24
Market Cap
84.2M
Industry
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Website
Listed
2023-08-09
Address
11611 N. MERIDIAN ST
CARMEL, IN 46032
Phone: (812) 689-0791
CARMEL, IN 46032
Phone: (812) 689-0791
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?97
Momentum?65
Short Sent.?60
Piotroski F-Score?3/9Weak
Altman Z-Score?4.71Safe
Confidence?49%Low
Short InterestElevated
Short % of Float?8.07%Elevated
Short Interest?507.5K
Days to Cover?3.7
Free Float6.3M
Avg Daily Volume137.7K
Settlement Date2026-06-15
Financial Health
Current Ratio?2.89Strong
Quick Ratio?2.81Strong
Cash Ratio?2.52Strong
Debt/Equity?0.02Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?14.89HIGH▾
Peers100
S&P12
P/S?19.99HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-10.9CHEAP▾
S&P97
EV/Sales?18.36HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-140.5%WEAK▾
S&P3
ROA?-92.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-6072095
Enterprise Value?$78.6M
Fundamentals ratios updated end of day